Related Experiment Videos
Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box
S C Stratton1, I J Beresford, F J Harvey
1Neuropharmacology Department, Glaxo Group Research, Ware, Hertfordshire, UK.
European Journal of Pharmacology
|December 21, 1993
Abstract:
The tachykinin NK2 receptor antagonists, GR100679 (0.02-200 micrograms/kg s.c.) and (+/-)-SR489698 (0.05-5.0 micrograms/kg s.c.), dose-dependently increased the time which mice spent in the light side of the light-dark box. There was no evidence of sedation or other over behaviours. The amplitudes of these effects were similar to that evoked by diazepam (1.75 mg/kg s.c.). These results indicate a disinhibitory action of NK2 antagonists on suppressed behaviours in a novel aversive environment. This suggests an involvement of NK2 receptors in anxiety-related behaviours.